Merus clinical trial for an experimental medicine, zenocutuzumab (MCLA-128), for cancer patients with solid tumors with an NRG1 Fusion.
View Top Employees from Merus N.VWebsite | http://nrg1.com |
Employees | View employees |
Industry | Manufacturing General, Manufacturing |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Merus N.V employee's phone or email?
The NAICS codes for Merus N.V are [325, 3254, 32].
The SIC codes for Merus N.V are [283, 28].